These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24074052)

  • 81. [3H]Org 43553, the first low-molecular-weight agonistic and allosteric radioligand for the human luteinizing hormone receptor.
    Heitman LH; Oosterom J; Bonger KM; Timmers CM; Wiegerinck PH; Ijzerman AP
    Mol Pharmacol; 2008 Feb; 73(2):518-24. PubMed ID: 17989351
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4).
    Smith E; Chase P; Niswender CM; Utley TJ; Sheffler DJ; Noetzel MJ; Lamsal A; Wood MR; Conn PJ; Lindsley CW; Madoux F; Acosta M; Scampavia L; Spicer T; Hodder P
    J Biomol Screen; 2015 Aug; 20(7):858-68. PubMed ID: 25877150
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
    Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
    J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
    [TBL] [Abstract][Full Text] [Related]  

  • 84. THRX-198321 is a bifunctional muscarinic receptor antagonist and beta2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner.
    Steinfeld T; Hughes AD; Klein U; Smith JA; Mammen M
    Mol Pharmacol; 2011 Mar; 79(3):389-99. PubMed ID: 21139051
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pharmacological analysis of the novel mode of interaction between xanomeline and the M1 muscarinic acetylcholine receptor.
    Christopoulos A; Parsons AM; El-Fakahany EE
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1220-8. PubMed ID: 10336509
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice.
    Woolley ML; Carter HJ; Gartlon JE; Watson JM; Dawson LA
    Eur J Pharmacol; 2009 Jan; 603(1-3):147-9. PubMed ID: 19111716
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor.
    Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Kimatrai Salvador M; Preti D; Aghazadeh Tabrizi M; Moorman AR; Vincenzi F; Borea PA; Varani K
    Eur J Med Chem; 2013 Sep; 67():409-27. PubMed ID: 23911855
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex.
    De Lorme KC; Grant MK; Noetzel MJ; Polson SB; El-Fakahany EE
    J Pharmacol Exp Ther; 2007 Dec; 323(3):868-76. PubMed ID: 17855477
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Discovery of a selective M₄ positive allosteric modulator based on the 3-amino-thieno[2,3-b]pyridine-2-carboxamide scaffold: development of ML253, a potent and brain penetrant compound that is active in a preclinical model of schizophrenia.
    Le U; Melancon BJ; Bridges TM; Vinson PN; Utley TJ; Lamsal A; Rodriguez AL; Venable D; Sheffler DJ; Jones CK; Blobaum AL; Wood MR; Daniels JS; Conn PJ; Niswender CM; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2013 Jan; 23(1):346-50. PubMed ID: 23177787
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M
    Long MF; Engers JL; Chang S; Zhan X; Weiner RL; Luscombe VB; Rodriguez AL; Cho HP; Niswender CM; Bridges TM; Conn PJ; Engers DW; Lindsley CW
    Bioorg Med Chem Lett; 2017 Nov; 27(22):4999-5001. PubMed ID: 29037946
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release.
    Foster DJ; Wilson JM; Remke DH; Mahmood MS; Uddin MJ; Wess J; Patel S; Marnett LJ; Niswender CM; Jones CK; Xiang Z; Lindsley CW; Rook JM; Conn PJ
    Neuron; 2016 Sep; 91(6):1244-1252. PubMed ID: 27618677
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Identification, expression and functional characterization of M4L, a muscarinic acetylcholine M4 receptor splice variant.
    Schober DA; Croy CH; Ruble CL; Tao R; Felder CC
    PLoS One; 2017; 12(12):e0188330. PubMed ID: 29211764
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
    Romagnoli R; Baraldi PG; IJzerman AP; Massink A; Cruz-Lopez O; Lopez-Cara LC; Saponaro G; Preti D; Aghazadeh Tabrizi M; Baraldi S; Moorman AR; Vincenzi F; Borea PA; Varani K
    J Med Chem; 2014 Sep; 57(18):7673-86. PubMed ID: 25181013
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M(4) muscarinic acetylcholine receptor agonists.
    Suwa A; Konishi Y; Uruno Y; Takai K; Nakako T; Sakai M; Enomoto T; Ochi Y; Matsuda H; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2909-12. PubMed ID: 24852118
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Allosteric modulation of a chemogenetically modified G protein-coupled receptor.
    Abdul-Ridha A; Lane JR; Sexton PM; Canals M; Christopoulos A
    Mol Pharmacol; 2013 Feb; 83(2):521-30. PubMed ID: 23197649
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple Orthosteric Binding Sites.
    Gregory KJ; Giraldo J; Diao J; Christopoulos A; Leach K
    Mol Pharmacol; 2020 Jan; 97(1):35-45. PubMed ID: 31704718
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Synthesis and Preliminary Evaluation of
    Deng X; Hatori A; Chen Z; Kumata K; Shao T; Zhang X; Yamasaki T; Hu K; Yu Q; Ma L; Wang G; Wang L; Shao Y; Josephson L; Sun S; Zhang MR; Liang S
    ChemMedChem; 2019 Feb; 14(3):303-309. PubMed ID: 30589226
    [TBL] [Abstract][Full Text] [Related]  

  • 98. High-Throughput Agonist Shift Assay Development for the Analysis of M
    Homsher MF; Beshore DC; Cassaday J; Squadroni B; Mohammed E; Hartnett M; Day S; Ma L; Pechter D; Smith MD; Monsma F; Zuck P; Finley MF; Uebele VN; Hermes JD
    SLAS Discov; 2017 Sep; 22(8):1060-1066. PubMed ID: 28426939
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Novel M
    Poslusney MS; Salovich JM; Wood MR; Melancon BJ; Bollinger KA; Luscombe VB; Rodriguez AL; Engers DW; Bridges TM; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2019 Feb; 29(3):362-366. PubMed ID: 30580918
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
    Romagnoli R; Baraldi PG; Lopez-Cara C; Cruz-Lopez O; Moorman AR; Massink A; IJzerman AP; Vincenzi F; Borea PA; Varani K
    Eur J Med Chem; 2015 Aug; 101():185-204. PubMed ID: 26141910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.